A detailed history of Wells Trecaso Financial Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wells Trecaso Financial Group, LLC holds 47,647 shares of BMY stock, worth $2.4 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
47,647
Previous 52,183 8.69%
Holding current value
$2.4 Million
Previous $2.68 Million 3.51%
% of portfolio
0.91%
Previous 1.08%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$47.98 - $54.4 $217,637 - $246,758
-4,536 Reduced 8.69%
47,647 $2.58 Million
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $469,043 - $559,698
-9,675 Reduced 15.64%
52,183 $2.68 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $90,887 - $101,626
-1,570 Reduced 2.48%
61,858 $3.59 Million
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $112,257 - $124,643
-1,762 Reduced 2.7%
63,428 $4.06 Million
Q1 2023

Apr 20, 2023

BUY
$65.71 - $74.53 $55,919 - $63,425
851 Added 1.32%
65,190 $4.52 Million
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $47,662 - $56,438
696 Added 1.09%
64,339 $0
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $8 - $4,994
65 Added 0.1%
63,643 $4.52 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $27,232 - $29,992
-375 Reduced 0.59%
63,578 $4.9 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $142,633 - $171,030
2,320 Added 3.76%
63,953 $4.67 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $98,893 - $115,286
1,844 Added 3.08%
61,633 $3.84 Million
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $65,797 - $77,072
1,112 Added 1.9%
59,789 $3.54 Million
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $187,896 - $204,619
3,035 Added 5.45%
58,677 $3.92 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $67,944 - $76,417
1,145 Added 2.1%
55,642 $3.51 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $190,715 - $216,115
3,303 Added 6.45%
54,497 $3.38 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $307,824 - $341,110
5,360 Added 11.69%
51,194 $3.09 Million
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $215,278 - $251,681
3,927 Added 9.37%
45,834 $2.7 Million
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $94,192 - $136,882
2,030 Added 5.09%
41,907 $2.34 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $24,605 - $32,095
500 Added 1.27%
39,877 $2.56 Million
Q3 2019

Oct 16, 2019

BUY
$42.77 - $50.71 $38,279 - $45,385
895 Added 2.33%
39,377 $2 Million
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $47,297 - $52,300
-1,060 Reduced 2.68%
38,482 $1.75 Million
Q1 2019

Apr 18, 2019

SELL
$45.12 - $53.8 $24,139 - $28,783
-535 Reduced 1.33%
39,542 $1.89 Million
Q4 2018

Jan 28, 2019

BUY
$48.76 - $63.23 $16,675 - $21,624
342 Added 0.86%
40,077 $2.08 Million
Q3 2018

Oct 22, 2018

SELL
$55.19 - $62.25 $51,326 - $57,892
-930 Reduced 2.29%
39,735 $2.47 Million
Q2 2018

Jul 25, 2018

SELL
$50.53 - $62.98 $98,280 - $122,496
-1,945 Reduced 4.56%
40,665 $2.25 Million
Q1 2018

Apr 23, 2018

BUY
$59.92 - $68.98 $362,935 - $417,811
6,057 Added 16.57%
42,610 $2.7 Million
Q4 2017

Apr 23, 2018

BUY
$59.94 - $65.35 $2.19 Million - $2.39 Million
36,553
36,553 $2.24 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $107B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wells Trecaso Financial Group, LLC Portfolio

Follow Wells Trecaso Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.